Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo

Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page

  1. Check
    3 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page. The Home link in the navigation appears removed, indicating a blocked access and altered navigation.
    Difference
    0.5%
    Check dated 2026-09-29T18:56:45.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with a minimal header and a Home link, replacing the prior study-record content. This reflects an access-denied state rather than the full study details.
    Difference
    18%
    Check dated 2026-09-22T20:56:26.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.6 to v3.7.0, indicating a maintenance update. No study data or core content of the page appears to have changed.
    Difference
    0.0%
    Check dated 2026-09-15T21:38:26.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.6.5 to v3.6.6, representing a minor site maintenance update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-09-01T20:12:57.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Synopsis Link appears on the Study Details page. A new sponsor-related block shows Boehringer Ingelheim as the sponsor with a 'Helpful Links Provided by' label and the text 'Drug and device information, study documents, and helpful links'.
    Difference
    0.2%
    Check dated 2026-08-25T21:57:21.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.6.5 was added, replacing the previous Revision: v3.6.4. This indicates a minor update to the page template or system without changing the study details.
    Difference
    0.0%
    Check dated 2026-08-11T22:50:26.000Z thumbnail image

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo

Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.